ストックスクリーナーアプリを入手
2.765
1.95%
-0.055
前日終値:
$2.82
開ける：
$2.83
24時間の取引高:
266.37K
Relative Volume:
0.40
時価総額：
$197.98M
収益：
$405.47M
当期純損益:
$53.66M
株価収益率:
3.8403
EPS:
0.72
ネットキャッシュフロー:
$131.28M
1週間 パフォーマンス:
+1.28%
1か月 パフォーマンス:
+2.79%
6か月 パフォーマンス:
-1.25%
1年 パフォーマンス:
-26.07%
1日の値動き範囲:
$2.715
$2.86
1週間の範囲:
$2.6417
$2.895
52週間の値動き範囲:
$2.08
$4.22
Orasure Technologies Inc Stock (OSUR) Company Profile
名前
Orasure Technologies Inc
セクター
電話
(503) 641-6115
住所
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, MDLN, RMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
2.76 | 202.29M | 405.47M | 53.66M | 131.28M | 0.72 |
|
ISRG
Intuitive Surgical Inc
|
479.31 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
178.31 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.44 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
43.80 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
246.24 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-01-03 | 再開されました | Evercore ISI | In-line |
| 2021-09-22 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | 開始されました | Evercore ISI | Outperform |
| 2020-08-10 | 開始されました | Citigroup | Buy |
| 2020-08-10 | 開始されました | JP Morgan | Neutral |
| 2020-08-07 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | 開始されました | Lake Street | Buy |
| 2020-04-21 | 再開されました | Stephens | Equal-Weight |
| 2018-10-23 | 再開されました | Raymond James | Mkt Perform |
| 2018-07-16 | ダウングレード | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | ダウングレード | Jefferies | Buy → Hold |
| 2017-02-09 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | 繰り返されました | Mizuho | Buy |
| 2015-05-07 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | 繰り返されました | Mizuho | Buy |
| 2014-06-12 | 繰り返されました | Canaccord Genuity | Buy |
| 2014-06-11 | 繰り返されました | Mizuho | Buy |
| 2012-12-21 | 開始されました | Mizuho | Buy |
| 2012-08-08 | アップグレード | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | ダウングレード | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Orasure Technologies Inc (OSUR) 最新ニュース
OraSure Technologies (NASDAQ:OSUR) Stock Price Crosses Above Two Hundred Day Moving AverageHere's What Happened - MarketBeat
OraSure makes job cuts as it ‘rebalances’ for future growth - Lehigh Valley Business
OraSure’s HIV self-test receives Health Canada license By Investing.com - Investing.com South Africa
Will OraSure Technologies Inc. stock benefit from automationJuly 2025 Final Week & Weekly High Potential Alerts - mfd.ru
Oral HIV self-test can now be sold in Canada in ‘key’ move - Global News
Canada’s first oral HIV self-test has been approved for sale - The Globe and Mail
OraSure (OSUR) Gains Health Canada Approval for OraQuick HIV Sel - GuruFocus
OraSure’s HIV self-test receives Health Canada license - Investing.com
Canada’s first oral HIV self-test lets people check at home - Stock Titan
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th - The Manila Times
OraSure Technologies, Inc. Schedules Fourth Quarter 2025 Earnings Conference Call for February 25, 2026 - Quiver Quantitative
OraSure Technologies Inc. kündigt Veröffentlichung von Finanzergebnissen an - Longbridge
OraSure trimming global workforce, including here in Lehigh Valley - WFMZ.com
Treasury Yields: How does OraSure Technologies Inc perform in inflationary periodsJuly 2025 Spike Watch & Smart Allocation Stock Reports - baoquankhu1.vn
OraSure Technologies (NASDAQ:OSUR) Share Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
OTC/DTC Infectious Disease Diagnostics Research Report 2026: Market Strategies, Trends, and Forecasts 2025-2029 - GlobeNewswire Inc.
Aug Rallies: Should I set a stop loss on PATH2025 Risk Factors & Long Hold Capital Preservation Tips - baoquankhu1.vn
Investment Review: Can OraSure Technologies Inc maintain sales growth2025 Support & Resistance & AI Powered Market Trend Analysis - baoquankhu1.vn
Aug Ideas: Is ATHM in a bullish channelEarnings Beat & Detailed Earnings Play Alerts - baoquankhu1.vn
OraSure files for FDA review of molecular self-test & Colli-Pee device - MSN
Risk Analysis: Does OraSure Technologies Inc. have a sustainable dividend2025 Retail Activity & Consistent Income Trade Recommendations - baoquankhu1.vn
Is OraSure Technologies Inc. stock attractive for growth ETFsPortfolio Value Report & Verified Short-Term Plans - bollywoodhelpline.com
Altai Capital nominates two directors to OraSure's board - MSN
The Truth About OraSure Technologies: Is This ‘Boring’ Test Maker Your Next Viral Money Play? - AD HOC NEWS
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital - The Manila Times
Altai Capital nominates two directors for OraSure Technologies board By Investing.com - Investing.com Nigeria
Altai Capital nominates two directors to OraSure board amid concerns By Investing.com - Investing.com Nigeria
Orasure Technologies confirms receipt of director nominations from Altai Capital - marketscreener.com
Orasure Technologies Confirms Receipt Of Director Nominations From Altai Capital - TradingView
OraSure (OSUR) Faces Board Nomination Challenge for 2026 - GuruFocus
Altai Capital nominates two directors for OraSure Technologies board - Investing.com
OraSure Technologies Confirms Altai Capital's Nominations for Board Election Ahead of 2026 Annual Meeting - Quiver Quantitative
Altai Capital nominates two directors to OraSure's board (update) (OSUR:NASDAQ) - Seeking Alpha
Altai Capital nominates two directors to OraSure board amid concerns - Investing.com
Altai pushes OraSure (NASDAQ: OSUR) board shakeup with two nominees at 2026 annual meeting - Stock Titan
Altai Capital Management Submits a Notice of its Intention to Nominate Candidates to OraSure Technologies Inc - marketscreener.com
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors - marketscreener.com
Aug Spikes: Is OraSure Technologies Inc stock undervalued vs historical averagesWeekly Stock Report & Weekly Consistent Profit Watchlists - Bộ Nội Vụ
Value Recap: Is OraSure Technologies Inc part of any major index2025 Major Catalysts & Accurate Trade Setup Notifications - baoquankhu1.vn
Movement Recap: Is OraSure Technologies Inc attractive for institutional investorsStop Loss & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
Aug Catalysts: How OraSure Technologies Inc stock trades before earnings2025 Short Interest & Safe Capital Growth Tips - Bộ Nội Vụ
Will OraSure Technologies Inc. stock deliver better than expected guidance2025 Technical Patterns & Consistent Return Strategy Ideas - Улправда
How OraSure Technologies Inc. stock trades before earningsJuly 2025 Sector Moves & Daily Volume Surge Trade Alerts - ulpravda.ru
OraSure submits CT/NG molecular self-test, Colli-Pee device for FDA review - MSN
OraSure Technologies (OSUR) Price - Zacks Investment Research
OraSure seeking FDA approval for pair of products - WFMZ.com
OraSure Files for FDA Review of Molecular Self-Test & Colli-Pee Device - sharewise.com
OraSure submits FDA applications for rapid STI test and collection device - Investing.com Nigeria
OraSure (OSUR) Seeks FDA Approval for New Diagnostic Solutions - GuruFocus
OraSure Seeks FDA Clearance for New STI Tests - TipRanks
OraSure submits FDA applications for rapid STI test and collection device By Investing.com - Investing.com South Africa
Orasure Technologies Inc (OSUR) 財務データ
収益
当期純利益
現金流量
EPS
Orasure Technologies Inc (OSUR) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Gagliano Nancy J | Director |
Nov 28 '25 |
Buy |
2.37 |
2,100 |
4,982 |
160,254 |
| Gagliano Nancy J | Director |
Feb 27 '25 |
Buy |
3.08 |
12,750 |
39,270 |
91,524 |
| EGLINTON MANNER CARRIE | President & CEO |
Feb 28 '25 |
Buy |
3.49 |
28,670 |
100,027 |
1,288,334 |
| EGLINTON MANNER CARRIE | President & CEO |
Feb 27 '25 |
Buy |
3.15 |
78,625 |
247,378 |
1,259,664 |
| Kenny John P. | Director |
Feb 27 '25 |
Buy |
3.17 |
47,659 |
151,217 |
70,915 |
| McGrath Kenneth J | Chief Financial Officer |
Feb 27 '25 |
Buy |
3.15 |
64,000 |
201,683 |
371,013 |
| Marmora Lelio | Director |
Feb 27 '25 |
Buy |
3.06 |
7,000 |
21,420 |
67,720 |
5.54%
大文字化:
|
ボリューム (24 時間):